The effect of feeding a low iron diet prior to and during gestation on fetal and maternal iron homeostasis in two strains of rat
© Cornock et al.; licensee BioMed Central Ltd. 2013
Received: 8 November 2012
Accepted: 9 April 2013
Published: 1 May 2013
Iron deficiency anaemia during pregnancy is a global problem, with short and long term consequences for maternal and child health. Animal models have demonstrated that the developing fetus is vulnerable to maternal iron restriction, impacting on postnatal metabolic and blood pressure regulation. Whilst long-term outcomes are similar across different models, the commonality in mechanistic events across models is unknown. This study examined the impact of iron deficiency on maternal and fetal iron homeostasis in two strains of rat.
Wistar (n=20) and Rowett Hooded Lister (RHL, n=19) rats were fed a control or low iron diet for 4 weeks prior to and during pregnancy. Tissues were collected at day 21 of gestation for analysis of iron content and mRNA/protein expression of regulatory proteins and transporters.
A reduction in maternal liver iron content in response to the low iron diet was associated with upregulation of transferrin receptor expression and a reduction in hepcidin expression in the liver of both strains, which would be expected to promote increased iron absorption across the gut and increased turnover of iron in the liver. Placental expression of transferrin and DMT1+IRE were also upregulated, indicating adaptive responses to ensure availability of iron to the fetus. There were considerable differences in hepatic maternal and fetal iron content between strains. The higher quantity of iron present in livers from Wistar rats was not explained by differences in expression of intestinal iron transporters, and may instead reflect greater materno-fetal transfer in RHL rats as indicated by increased expression of placental iron transporters in this strain.
Our findings demonstrate substantial differences in iron homeostasis between two strains of rat during pregnancy, with variable impact of iron deficiency on the fetus. Whilst common developmental processes and pathways have been observed across different models of nutrient restriction during pregnancy, this study demonstrates differences in maternal adaptation which may impact on the trajectory of the programmed response.
KeywordsPregnancy Iron Placenta Liver Maternal Fetus Development Rat
The World Health Organisation estimates that anaemia affects nearly two billion people worldwide, with iron deficiency anaemia accounting for 75-80% of the total burden [1, 2]. Iron deficiency is most common in infants, adolescent girls and women of child bearing age  and the prevalence during pregnancy is a global problem, ranging from 25% in Europe and the Americas to 48% and 57% in East Asia and Africa respectively . It is of particular importance during pregnancy, as anaemia can result in preterm delivery of the fetus, low birth weight  and increased perinatal mortality . In addition, iron deficiency during pregnancy has been shown to alter placental vascularisation  and cytokine expression  in the rat, and low maternal haemoglobin has been linked with the formation of an enlarged placenta in humans .
Iron deficiency during pregnancy has also been suggested to have longer-term consequences. In human populations, low maternal haemoglobin during pregnancy has been associated with high blood pressure in the resulting offspring during childhood . In animals, long-term effects of exposure to a prenatal low iron diet include raised blood pressure [10–13], altered renal morphology and nephron number in the offspring [14, 15] and altered lipid and glucose homeostasis . Studies regarding the effect of iron deficiency during pregnancy on postnatal blood pressure have been carried out in rats of the Wistar strain  and Rowett Hooded Lister strain (RHL) , with the offspring of both strains exhibiting raised blood pressure in adulthood when exposed to a prenatal low iron diet.
Rodent models of nutritional insult during pregnancy are extensively used to investigate phenomena associated with programming of physiology and disease . It is widely assumed that data obtained from rat and mouse studies are broadly comparable and little consideration has been given to variation between strains within a species. Earlier work reporting long-term effects of iron deficiency during pregnancy have used different strains (RHL [11, 17], Wistar , Sprague Dawley ). Whilst the long-term outcomes for the developing fetus are similar in terms of raised blood pressure, it is not known whether these programmed attributes arise in response to similar maternal adaptations to the nutritional insult across all strains. This knowledge is required to improve understanding of the mechanisms of nutritional programming. Previous work in the RHL strain identified alterations in iron homeostasis in response to a low iron diet during pregnancy [17, 18]. This present study aimed to extend these findings to the more widely used Wistar strain of rat, and to examine any differences between the strains in terms of iron homeostasis and response to a low iron diet.
Attention was focussed on iron uptake (involving the transferrin receptor, TfR), transport within the cell (involving the divalent metal transporter DMT1+IRE), iron export (involving ferroportin) and a protein involved in regulation of these transporters (hepcidin). Finally, expression of ferroxidase molecules (ceruloplasmin and hephaestin) was examined due to their importance in the oxidation of Fe2+ to Fe3+ to enable iron to be carried in the circulation attached to transferrin. It was expected that the feeding of a low iron diet prior to and during pregnancy would impact on the iron status of pregnant rats and their fetuses, producing an anaemic state. It was hypothesised that the placental expression of proteins associated with iron transport from the pregnant rat to fetus would be altered in both strains of rat. It was further hypothesised that iron deficiency would influence the transfer of iron between mother and fetus across the placenta.
All animal experiments were performed under license from the United Kingdom Home Office in accordance with the 1986 Animals (Scientific Procedures) Act and following approval from the University of Nottingham Ethics Committee. Virgin female Wistar (n=20) and RHL (n=20) rats were fed either a control iron (50 mg/kg) or a low iron (7.5 mg/kg) diet from weaning and for 4 weeks prior to mating. Animal procedures in the Wistar strain were performed in the BioResources Unit at the University of Nottingham, whilst experiments in the Rowett Hooded Lister strain were performed at the Rowett Institute of Nutrition and Health (RINH), Aberdeen. All experimental diets were prepared at RINH as previously described  and fed ad libitum. The animals were group housed in cages under constant temperature and humidity, and under the same conditions at both sites. Controlled illumination with a 12 h light–dark cycle was maintained to assure regular oestrous cycles. Mating was confirmed by the presence of a semen plug found on the cage floor (gestational day 0), and dietary intervention continued throughout gestation. Dams were weighed daily and their feed intake recorded during the whole experimental period. Dams were euthanased on day 21 of gestation by cervical dislocation under terminal anaesthesia with isoflourane, and fetuses by cervical dislocation. Fetuses were counted, sexed and individually weighed. Placentas and fetal organs were also individually weighed. Placentas and maternal and fetal livers were removed, weighed and snap frozen in liquid nitrogen, and stored at −80°C until analysis. Fetal sex was determined, and three males and three females (where possible) were pooled to provide a pooled male and a pooled female sample for each litter. This ensured that there was sufficient tissue within each sample to be used for all subsequent analyses.
Duodenal samples were collected from non-pregnant female Wistar and RHL rats maintained on the control diet for a period of 6 weeks from weaning. All other conditions were the same as described previously. Following euthanasia by cervical dislocation under terminal anaesthesia with isoflourane, the gastrointestinal tract was excised and a 10 cm section of duodenum removed from immediately downstream of the pyloric sphincter. This section was sliced longitudinally into two, snap frozen in liquid nitrogen, and stored at −80°C until analysis.
Tissue iron determination
Determination of tissue iron content was carried out at the Rowett Institute of Nutrition and Health as previously described . Briefly, iron content was determined by graphite-furnace atomic spectrophotometry. To distinguish between haem and non-haem iron, samples were treated with 20% tri-chloroacetic acid.
RNA extraction and real-time RT-PCR
All mRNA expression analyses were conducted at the University of Nottingham. RNA was extracted from snap-frozen placenta and liver tissue by the TRIzol procedure (Invitrogen, UK) and subjected to DNAse treatment (Promega, UK), phenol-chloroform extraction and ethanol precipitation. RNA was reverse transcribed using MMLV reverse transcriptase (Promega, UK). Real-time PCR primers for TfR, DMT1+IRE and hepcidin have previously been described [17, 18]. Primer sequences for ceruloplasmin, hephaestin and β-actin were designed using Primer Express (v1.5; Applied Biosystems) and were as follows: ceruloplasmin [GenBank NM_012532] forward primer 5’-GAGACAAAGTTTCTGTTACGTAAAGA-3’, reverse primer 5’-GGTAGATGGCCCCCTCG-3’; hephaestin [GenBank NM_133304] forward primer 5’-TCCAATCGAATGCATGCT-3’, reverse primer 5’-AACATAACCCCATGTACA-3’; β-actin [genBank NM_031144] forward primer 5’-TTCAACACCCCAGCCATGT-3’, reverse primer 5’-GTGGTACGACCAGAGGCATACA-3’; IREG [genBank NM_133315] forward primer 5’-CATAATCTCCGTCAGCCTGCT-3’, reverse primer 5’-CACAGTCAAATCAAAGGACCAAAG-3’. Primers were purchased from MWG Biotech, Germany. Real time PCR was performed on the Lightcycler 480 system (Roche, UK). Placental mRNA expression data was normalised to β-actin expression. The expression of a number of housekeeping genes (β -actin, GAPDH and cyclophilin A) were found to be influenced by experimental conditions in maternal and fetal liver. Therefore, expression data in these tissues was normalised to the quantity of cDNA present in each sample, indicated by the fluorescence at 80°C . Briefly, Oligreen stock solution (Invitrogen, UK) was diluted 1:200 in 1xTE buffer to produce a working solution, 5 μl of which was mixed with an equal volume of sample in a 384 well plate, in duplicate and the fluorescence measured at 80°C using the Lightcycler 480 system (Roche).
All protein expression analyses were conducted at the University of Nottingham. Tissues were homogenised in an extraction buffer containing 50 mM Tris/HCL and 5 mM EDTA. Protein concentration was determined by the Bradford assay . Samples were diluted with an equal volume of loading buffer [4% (w/v) SDS, 125 mM Tris/HCl pH 6.8, 20% (v/v, 87%) glycerol, 0.1M dithiothreitol], and adjusted to equal protein concentration. Samples were then heated at 90°C for 5 minutes before being run on SDS-polyacrylamide gels. Electrophoresis was carried out in a 10× Tris/glycine/SDS running buffer (National Diagnostics, USA). Following electrophoretic separation, proteins were transferred to nitrocellulose membrane (GE Healthcare, UK). Blots were probed with the following anti-rat antibodies: TfR diluted 1:1000 (Serotec) for both fetal liver and placental samples, ferroportin (Alpha diagnostics) diluted 1:30,000 for placental samples and 1:700 for fetal liver samples, Tubulin (Abcam, UK) diluted 1:60,000 for both fetal liver and placental samples. Blots were developed using ECL reagents and treated with goat anti-rabbit (ferroportin and tubulin) or sheep anti-mouse (TfR) horse radish peroxidise linked secondary antibody (GE Healthcare). Blots were exposed to Hyperfilm ECL (GE Healthcare) and protein bands quantified using a Quantity-One Multi Analyst system (BioRad, UK). Protein expression was normalised to tubulin expression.
Data were analysed using SPSS (v15) and by carrying out an ANOVA or independent samples T-test where appropriate. All fetal data were analysed by three-way ANOVA to assess the effects of diet, strain and sex. The only exception to this is for the fetal liver protein expression data, where a significant difference in expression of the housekeeping protein was found between strains. Wistar and RHL data was therefore analysed separately for these two variables. There was no effect of fetal sex on any of the parameters examined in either strain or interaction of fetal sex with any of the other factors being examined. Data is therefore presented for male and females combined. Some litters contained less than three males or females and so did not provide sufficient fetal material for all analyses. The number of samples in each analysis is therefore variable. No data was actively excluded for any reason other than a missing value.
Maternal and fetal weights
Maternal body weight at mating (g)
204.4 ± 3.7b
203.0 ± 3.5b
224.2 ± 4.3a
225.7 ± 6.1a
Pregnancy weight gain (g)
146.0 ± 5.2a
136.7 ± 5.8a
107.9 ± 4.7b
106.2 ± 4.9b
13.2 ± 0.8
13.6 ± 1.2
11.2 ± 0.7
12.0 ± 0.9
Mean fetal weight (g)
4.7 ± 0.1a
4.0 ± 0.2b
4.5 ± 0.1a
4.6 ± 0.1a
Mean placental weight (g)
0.51 ± 0.01a
0.55 ± 0.04a
0.48 ± 0.04b
0.43 ± 0.02b
Maternal and fetal liver and placental iron content
Maternal liver iron homeostasis
Fetal liver iron homeostasis
Placental iron transport
Duodenal iron transport
Given the clear strain differences in maternal liver iron content, it was of interest to determine whether there was any difference in intestinal iron transport between the strains. When normalised to β-actin, expression of DMT1+IRE (RHL: 0.80 ± 0.12, Wistar: 0.76 ± 0.18), ferroportin (RHL: 1.17 ± 0.09, Wistar: 1.25 ± 0.11) and hephaestin (RHL: 0.81 ± 0.13, Wistar: 0.88 ± 0.11) mRNA in the duodenum did not differ between strains of rat when fed a control diet for 6 weeks in the non-pregnant state.
Long-term effects of iron deficiency during pregnancy on offspring blood pressure have been demonstrated previously in several strains of rat [10, 12, 17, 18]. The long-term outcomes for the developing fetus are similar across these studies, and whilst it is assumed that these programmed attributes arise in response to identical maternal adaptations to the nutritional insult across all strains, this has never been directly assessed. This knowledge is required to improve understanding of the mechanisms of nutritional programming, which are currently thought to involve modification of fetal gene expression and resetting of organ structure, cellular function and endocrine regulation . Previous work in the RHL strain identified alterations in iron homeostasis in response to a low iron diet during pregnancy [17, 18]. This present study aimed to extend these findings to the more widely used Wistar strain of rat, and to examine any differences between the strains in terms of iron homeostasis and response to a low iron diet.
This study clearly demonstrates that the maternal and fetal livers are very sensitive to the feeding of a low iron diet prior to and during gestation. Additionally, whilst the total iron content of the placenta was unaffected by diet, a reduction in placental non-haem iron was observed in response to a low iron diet in both strains. These data are in good agreement with previous work with the RHL strain [7, 17]. The reduction in maternal liver content in response to dietary restriction was associated with changes in the expression of key regulators of iron transport. Expression of the transferrin receptor (TfR) mRNA was up-regulated in the maternal liver by more than two-fold in both strains of rat. This is interpreted as a compensatory response to increase iron uptake into the liver cells and has previously been shown to be reversed by iron supplementation at selected points during pregnancy in the RHL . Maternal hepatic hepcidin mRNA expression was vastly down-regulated in response to the feeding of a low iron diet in both strains of rat, almost to the point of being undetectable. Decreased hepcidin expression has previously been observed  and can be reversed by supplementation of iron during the second half of rat pregnancy . As hepcidin prevents iron efflux [22, 23], down-regulation may therefore contribute to meeting the greater requirements for iron during pregnancy.
Maternal ceruloplasmin mRNA expression was found to be unaffected by the feeding of a low iron diet, suggesting that transcriptional regulation is not necessarily related to the level of iron efflux from the cell. There has previously been contradictory evidence published regarding the sensitivity of ceruloplasmin to iron status [24–26]. However, in an in vivo rat model, there was no effect of iron status on plasma ceruloplasmin concentration or activity or hepatic mRNA expression . Instead, it has been suggested that oxidase activity could be altered indirectly via changes in redox state . Similarly to the maternal liver, TfR protein expression was increased in the fetal livers in response to prenatal dietary iron restriction, but only in the RHL strain. No change in expression of ferroportin was observed in either strain. However, the reduction in hepcidin mRNA expression in the fetal liver in response dietary iron restriction in both strains may modulate ferroportin internalisation via ubiquitination [28, 29].
Placental expression of the transferrin receptor was increased in response to dietary iron restriction in both strains of rat, as previously observed in the RHL . This may act to enhance iron uptake into the placenta and optimise transfer to the fetus. There was no associated increase in ferroportin protein expression, but its responsiveness to dietary iron status may instead be related to the observed reduction in fetal hepcidin mRNA expression modulating the internalisation of placental ferroportin [17, 22, 28]. In both strains of rat, placental DMT1+IRE mRNA expression was increased in response to dietary iron restriction, which would act to allow release of iron from intracellular vesicles. This is in agreement with previous work with the RHL , and suggests that adaptive mechanisms optimise the availability of transporters that allow iron to cross the placenta. However, it must be noted that work with a murine DMT1 knock-out model indicated that this transporter does not play an essential role in materno-fetal iron transfer and that another transporter must be responsible for iron uptake by fetal-derived cells .
Interestingly, there was considerable difference in liver iron content between the strains, with Wistar dams having approximately twice the quantity of iron present in their livers in comparison to RHL rats. This suggests greater promotion or efficiency of absorption and storage of iron in the maternal liver. Wistar dams also exhibited higher placental total and haem iron content in comparison to RHLs, which was associated with a greater placental weight. The opposite was observed in the fetal liver, where total iron content was significantly higher in fetuses of the RHL strain. This direct comparison of iron status between two different strains of rat highlights the care which needs to be taken when comparing findings from different experimental models and suggests that programmed phenomena, such as hypertension, do not necessarily arise from similar maternal adaptations to nutritional insults across strains or species. Whilst our research has identified common developmental processes and pathways which are affected across different strains and dietary insults during pregnancy, there may be other differences in response which impact on the progression of the programmed phenomenon . Importantly, the liver iron content of the iron restricted Wistar rat was actually higher than the liver iron content of the control RHL rat, which demonstrates the inherent difficulty in labelling treatment groups as ‘deficient’ in comparison to an internal control in the absence of clinical thresholds.
The data suggests greater maternal to fetal iron transfer in the RHL rats, despite a reduction in placental weight in response to low iron diet in this strain only. This is consistent with the increased expression of placental iron transporters in this strain. Placental ferroportin protein and DMT1+IRE expression were significantly higher in rats of the RHL strain compared to the Wistar strain, which may account for a greater transfer of iron to the fetus at the expense of maternal liver iron stores. RHL rats also tended to have lower maternal liver TfR expression, although this marginally failed to reach statistical significance. Hepcidin mRNA expression was shown to be significantly lower in RHL fetal livers compared to Wistars, which may permit more ferroportin to be present at the membrane to facilitate increased transport of iron to other tissues. Unfortunately direct comparisons of the fetal liver iron transporters could not be made between strains, as expression of the normalising protein (tubulin) differed between strains, perhaps indicating structural (cytoskeletal) differences between liver cells of the two strains of rat. However, the lack of response of TfR protein expression to dietary iron restriction in Wistar fetal livers may explain the lower fetal liver iron content in this strain.
It has been previously shown that 72% of iron in the fetal liver is derived from maternal iron stores, and that the remaining 28% is from maternal dietary absorption . We therefore went on to consider whether the differences in maternal iron status between the strains could be due to differences in absorption of iron from the diet in the duodenum. Iron absorption is known to be enhanced when the body is iron deficient , as indicated by increased expression of DMT1 in the duodenum . However, no significant differences in duodenal DMT1+IRE, ferroportin or hephaestin expression were observed between the two strains of rat. The differences in maternal liver iron content cannot, therefore, be explained through differences in the expression of intestinal iron transporters, although a differential response to pregnancy cannot be excluded at this point. It is concluded that the differences in maternal liver iron content observed between the two strains are most likely a result of differences in the efficiency of placental transfer of iron to the fetus, as indicated by the greater fetal hepatic iron content and increased placental expression of iron export molecules observed in the RHL strain. Despite this, birth weight was reduced in response to iron restriction in the RHL strain only, indicating that the adaptive responses protected fetal iron status but not birth weight.
Our findings demonstrate considerable differences in iron homeostasis between two strains of rat during pregnancy. While the impact of the iron deficient diet on maternal and fetal hepatic iron content was similar, the differences in baseline iron content are not. The results suggest that rats of the RHL strain promote greater transfer of iron across the placenta to the fetus in comparison to the Wistar rats, which maintain maternal iron status at the detriment of the fetus. The study suggests that whilst common developmental processes and pathways are affected across different strains and dietary insults during pregnancy , there may be other differences in baseline parameters or response to treatment which impact on the trajectory of the programmed phenomenon. This has important implications for studies of human health. Understanding how populations adapt to iron deficiency anaemia during pregnancy, and the impact of this on placental transfer and fetal iron status, is of considerable importance given the global burden of iron deficiency anaemia.
This study was supported by the BBSRC project grant BB/F005245/1 and a BBSRC studentship awarded to RC. The authors acknowledge the support of the animal technicians within the Biosciences Resources Unit at the University of Nottingham (Richard Plant, Carol Armett and Sarah Kirkland) and the Rowett Institute for Nutrition and Health (Donna Wallace and staff in the BSU), and Helen Hayes at the Rowett Institute for Nutrition and Health for laboratory assistance.
- World Health Organisation: Assessing the iron status of populations. 2007, Geneva: WHO
- World Health Organisation: Worldwide prevalence of anaemia 1993–2005. WHO Global Database on Anaemia. 2008, Geneva: WHO
- Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL: Prevalence of iron deficiency in the United States. JAMA. 1997, 277: 973-976. 10.1001/jama.1997.03540360041028.View ArticlePubMed
- Scholl TO, Hediger ML, Fischer RL, Shearer JW: Anemia vs iron deficiency - increased risk of preterm delivery in a prospective study. Am J Clin Nutr. 1992, 55: 985-988.PubMed
- Lone FW, Qureshi RN, Emanuel F: Maternal anaemia and its impact on perinatal outcome. Trop Med Int Health. 2004, 9: 486-490. 10.1111/j.1365-3156.2004.01222.x.View ArticlePubMed
- Lewis RM, Doherty CB, James LA, Burton GJ, Hales CN: Effects of maternal iron restriction on placental vascularization in the rat. Placenta. 2001, 22: 534-539. 10.1053/plac.2001.0679.View ArticlePubMed
- Gambling L, Charania Z, Hannah L, Antipatis C, Lea RG, McArdle HJ: Effect of iron deficiency on placental cytokine expression and fetal growth in the pregnant rat. Biol Reprod. 2002, 66: 516-523. 10.1095/biolreprod66.2.516.View ArticlePubMed
- Godfrey KM, Redman CWG, Barker DJP, Osmond C: The effect of maternal anemia and iron-deficiency on the ratio of fetal weight to placental weight. BJOG. 1991, 98: 886-891. 10.1111/j.1471-0528.1991.tb13510.x.View Article
- Godfrey KM, Forrester T, Barker DJP, Jackson AA, Landman JP, Hall JS, Cox V, Osmond C: Maternal nutritional-status in pregnancy and blood-pressure in childhood. BJOG. 1994, 101: 398-403. 10.1111/j.1471-0528.1994.tb11911.x.View Article
- Crowe C, Dandekar P, Fox M, Dhingra K, Bennet L, Hanson MA: The effects of anemia on heart, placenta and body-weight, and blood-pressure in fetal and neonatal Rats. J Physiol. 1995, 488: 515-519.PubMed CentralView ArticlePubMed
- Gambling L, Dunford S, Wallace DI, Zuur G, Solanky N, Kaila S, Srai S, McArdle HJ: Iron deficiency during pregnancy affects postnatal blood pressure in the rat. J Physiol. 2003, 552: 603-610. 10.1113/jphysiol.2003.051383.PubMed CentralView ArticlePubMed
- Lewis RM, Forhead AJ, Petry CJ, Ozanne SE, Hales CN: Long-term programming of blood pressure by maternal dietary iron restriction in the rat. Brit J Nutr. 2002, 88: 283-290. 10.1079/BJN2002656.View ArticlePubMed
- Lewis RM, Petry CJ, Ozanne SE, Hales CN: Effects of maternal iron restriction in the rat on blood pressure, glucose tolerance, and serum lipids in the 3-month-old offspring. Metab Clin Exp. 2001, 50: 562-567. 10.1053/meta.2001.22516.View ArticlePubMed
- Lisle SJM, Lewis RM, Petry CJ, Ozanne SE, Hales CN, Forhead AJ: Effect of maternal iron restriction during pregnancy on renal morphology in the adult rat offspring. Brit J Nutr. 2003, 90: 33-39. 10.1079/BJN2003881.View ArticlePubMed
- Swali A, McMullen S, Hayes H, Gambling L, McArdle HJ, Langley-Evans SC: Cell Cycle Regulation and Cytoskeletal Remodelling Are Critical Processes in the Nutritional Programming of Embryonic Development. PLoS One. 2011, 6 (8): e23189-10.1371/journal.pone.0023189.PubMed CentralView ArticlePubMed
- McMullen S, Mostyn A: Animal models for the study of the developmental origins of health and disease. Proc Nutr Soc. 2009, 68: 306-320. 10.1017/S0029665109001396.View ArticlePubMed
- Gambling L, Czopek A, Andersen HS, Holtrop G, Srai SKS, Krejpcio Z, McArdle HJ: Fetal iron status regulates maternal iron metabolism during pregnancy in the rat. Am J Physiol Regul Integr Comp Physiol. 2009, 296: R1063-R1070. 10.1152/ajpregu.90793.2008.View ArticlePubMed
- Gambling L, Andersen HS, Czopek A, Wojciak R, Krejpcio Z, McArdle HJ: Effect of timing of iron supplementation on maternal and neonatal growth and iron status of iron-deficient pregnant rats. J Physiol. 2004, 561: 195-203. 10.1113/jphysiol.2004.068825.PubMed CentralView ArticlePubMed
- Rhinn H, Scherman D, Escriou V: One-step quantification of single-stranded DNA in the presence of RNA using Oligreen in a real-time polymerase chain reaction thermocycler. Anal Biochem. 2008, 372: 116-118. 10.1016/j.ab.2007.08.023.View ArticlePubMed
- Bradford MM: Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.View ArticlePubMed
- Langley-Evans SC, McMullen S: Developmental Origins of Adult Disease. Med Princ Pract. 2010, 19: 87-98. 10.1159/000273066.View ArticlePubMed
- Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004, 306: 2090-2093. 10.1126/science.1104742.View ArticlePubMed
- Darshan D, Anderson GJ: Liver-gut axis in the regulation of iron homeostasis. World J Gastroenterol. 2007, 13: 4737-4745.PubMed CentralView ArticlePubMed
- Mukhopadhyay CK, Attieh ZK, Fox PL: Role of ceruloplasmin in cellular iron uptake. Science. 1998, 279: 714-717. 10.1126/science.279.5351.714.View ArticlePubMed
- Tran T, Ashraf M, Jones L, Westbrook T, Hazegh-Azam M, Linder MC: Dietary iron status has little effect on expression of ceruloplasmin but alters that of ferritin in rats. J Nutr. 2002, 132: 351-356.PubMed
- Fosset C, McGaw BA, Abramovich D, McArdle HJ: Interrelations between ceruloplasmin and Fe status during human pregnancy. Biol Trace Elem Res. 2004, 98: 1-12. 10.1385/BTER:98:1:01.View ArticlePubMed
- Jacob RA, Skala JH, Omaye ST, Turnlund JR: Effect of varying ascorbic-acid intakes on copper absorption and ceruloplasmin levels of young men. J Nutr. 1987, 117: 2109-2115.PubMed
- Qiao B, Sugianto P, Fung E, del-Castillo-Rueda A, Moran-Jimenez MJ, Ganz T, Nemeth E: Hepcidin-Induced Endocytosis of Ferroportin Is Dependent on Ferroportin Ubiquitination. Cell Metab. 2012, 15: 918-924. 10.1016/j.cmet.2012.03.018.PubMed CentralView ArticlePubMed
- Tussing-Humphreys L, Pustacioglu C, Nemeth E, Braunschweig C: Rethinking Iron Regulation and Assessment in Iron Deficiency, Anemia of Chronic Disease, and Obesity: Introducing Hepcidin. J Acad Nutr Diet. 2012, 112: 391-400. 10.1016/j.jada.2011.08.038.PubMed CentralView ArticlePubMed
- Gunshin H, Fujiwara Y, Custodio AO, DiRenzo C, Robine S, Andrews NC: Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest. 2005, 115: 1258-1266.PubMed CentralView ArticlePubMed
- Murray MJ, Stein N: Contribution of Maternal Iron Stores to Fetal Iron in Rats. J Nutr. 1970, 100: 1023-1025.PubMed
- Cox TM, Odonnell MW: Studies on the control of iron uptake by rabbit small intestine. Brit J Nutr. 1982, 47: 251-258. 10.1079/BJN19820033.View ArticlePubMed
- Fleming RE, Migas MC, Zhou XY, Jiang JX, Britton RS, Brunt EM, Tomatsu S, Waheed A, Bacon BR, Sly WS: Mechanism of increased iron absorption in murine model of hereditary hemochromatosis: Increased duodenal expression of the iron transporter DMT1. Proc Natl Acad Sci USA. 1999, 96: 3143-3148. 10.1073/pnas.96.6.3143.PubMed CentralView ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.